SCHEMBL10145462

SCHEMBL10145462

CCN(CC)c1ccc2c(c1)Oc1cc(C(C)(C)C)c(Cl)cc1C21OC(=O)c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.51
MAPT P10636 5/20 0.48
FTO Q9C0B1 4/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
HPGD P15428 4/20 0.48
TDP1 Q9NUW8 4/20 0.48
HTT P42858 3/20 0.48
CYP2C19 P33261 2/20 0.48
RECQL P46063 1/20 0.48
BLM P54132 1/20 0.48
SMAD3 P84022 1/20 0.48
PRMT1 Q99873 1/20 0.48
ACE2 Q9BYF1 1/20 0.48
ALDH1A1 P00352 4/20 0.45
LMNA P02545 3/20 0.45
USP2 O75604 1/20 0.45
CA12 O43570 4/20 0.44
CA1 P00915 4/20 0.44
CA2 P00918 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10145459 0.89 FTO (0.51) CYP3A4MAPTFTOMEN1KMT2A
SCHEMBL6411659 0.88 CYP3A4 (0.53) CYP3A4MAPTFTOMEN1KMT2A
SCHEMBL10175963 0.88 CYP3A4 (0.53) CYP3A4MAPTFTOMEN1KMT2A
SCHEMBL29562657 0.88 CYP3A4 (0.53) CYP3A4MAPTFTOMEN1KMT2A
SCHEMBL21440424 0.87 CYP3A4 (0.61) CYP3A4MAPTFTOMEN1KMT2A
SCHEMBL31150744 0.87 CYP3A4 (0.64) CYP3A4MAPTFTOMEN1KMT2A
SCHEMBL52075 0.87 CYP3A4 (0.64) CYP3A4MAPTFTOMEN1KMT2A
SCHEMBL29369814 0.87 CYP3A4 (0.64) CYP3A4MAPTFTOMEN1KMT2A
SCHEMBL6405281 0.86 CYP3A4 (0.58) CYP3A4MAPTFTOMEN1KMT2A
SCHEMBL275739 0.86 CYP3A4 (0.60) CYP3A4MAPTFTOMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2250177-B1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES VERSITECH LTD (CN) 2014-06-18 EP disclosed
US-8114904-B2 Luminescence quenchers and fluorogenic probes for detection of reactive species Versitech Limited & Morningside Ventures Limited (CN) 2012-02-14 US disclosed
US-8114904-B2 Luminescence quenchers and fluorogenic probes for detection of reactive species Versitech Limited & Morningside Ventures Limited (CN) 2012-02-14 US disclosed
US-20090253118-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES VERSITECH LIMITED (CN) 2009-10-08 US disclosed
US-20090253118-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES VERSITECH LIMITED (CN) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253118-A1 LUMINESCENCE QUENCHERS AND FLUOROGENIC PROBES FOR DETECTION OF REACTIVE SPECIES ROS1, LPO, HMOX1 CYP3A4 508/4885MAPT 4349/4885FTO 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.